期刊文献+

肺腺癌中RNPC1蛋白、EGFRv Ⅲ蛋白表达水平及意义 被引量:2

Expression and significance of RNPC1 protein and EGFRv Ⅲ protein in lung adenocarcinoma
下载PDF
导出
摘要 目的探讨肺腺癌中RNPC1蛋白、EGFRvⅢ蛋白表达水平及意义。方法选取2015年1月至2018年4月我院保存的肺腺癌组织标本89例,同时选取癌旁组织作为对照组,采用Western blot检测RNPC1蛋白、EGFRvⅢ蛋白表达。结果肺腺癌组织RNPC1和EGFRvⅢ蛋白相对表达量分别为(0.833±0.122)和(0.910±0.115),明显高于癌旁组织(P<0.05);肺腺癌Ⅲ期、有淋巴结转移患者RNPC1蛋白相对表达量分别为(0.892±0.115)和(0.898±0.120),明显高于Ⅰ~Ⅱ期、无淋巴结转移患者(P<0.05);肺腺癌女性、中低分化患者EGFRvⅢ蛋白相对表达量分别为(0.960±0.139)和(0.933±0.112),明显高于男性、高分化患者(P<0.05)。结论肺腺癌中RNPC1蛋白、EGFRvⅢ蛋白表达明显升高,与临床病理特征有一定关系,值得进一步研究。 Objective To investigate the expression and significance of RNPC1 protein and EGFRvⅢprotein in lung adenocarcinoma.Methods 89 lung adenocarcinoma specimens from January 2015 to April 2018 were selected,and the para cancerous tissue were selected as the control group.Western blot was used to detect the expression of RNPC1 protein and EGFRv III protein.Results The relative expression of RNPC1 and EGFRvⅢprotein in lung adenocarcinoma tissue were(0.833±0.122)and(0.910±0.115),which were significantly higher than that of para cancerous tissue(P<0.05).The relative expression of RNPC1 protein in patients with stageⅢof lung adenocarcinoma and lymph node metastasis were(0.892±0.115)and(0.898±0.120),which were significantly higher than that in stageⅠtoⅡand no lymph node metastases(P<0.05).The relative expression of EGFRvⅢprotein in female,middle and low differentiation were(0.960±0.139)and(0.933±0.112),which were significantly higher than that in male and high differentiated patients(P<0.05).Conclusion The expression of RNPC1 protein and EGFRvⅢprotein in lung adenocarcinoma are increased significantly,which are related to clinicopathological features,and is worthy of further study.
作者 韩丽丽 HAN Li-li(Department of Respiratory Medicine,Zhoukou Central Hospital,Zhoukou,Henan 466000,China)
出处 《临床肺科杂志》 2019年第7期1278-1281,共4页 Journal of Clinical Pulmonary Medicine
关键词 肺腺癌 RNPC1蛋白 EGFRvⅢ蛋白 临床病理特征 lung adenocarcinoma RNPC1 protein EGFRv Ⅲ protein clinicopathological features
  • 相关文献

参考文献11

二级参考文献67

  • 1石景森.胆囊癌确定治疗的思维程序[J].中华肝胆外科杂志,2006,12(3):157-158. 被引量:18
  • 2Croce CM. Oncogenes and oancer[ J]. N Engl J Med,2008 ,358 (5 ):502-505.
  • 3Chen X,Hu ZB, Wang WJ, et al.(ientification of ten senim microH-NAs from a genome-wide serum microRNA expression profile as novelnoninvasive biomarkers for nonsmall cell lung cancer diagnosis[ J] ? IniJ Cancer,2012,130(7) : 1620-1628.
  • 4Tang DF,Shen Y, Wang MZ,et al. Identification of plasma microRNAsas novel noninvasive biomarkers for early detection of lung cancer [ J ].Eur J Cancer Prev,2013 ,22(6) :540-548.
  • 5Tristen S. Park,Steven A. Rosenberg,Richard A. Morgan.Treating cancer with genetically engineered T cells[J]. Trends in Biotechnology . 2011 (11)
  • 6Kagohashi K, Satoh H, Kurishima K, et al. Squamous cell carcinoma antigen in lung cancer and nonmalignant res- piratory diseases[J]. Lung,2008,186(5) :323-326.
  • 7Jang SM,Kim JW,Kim CH,et al. pl9(ras)Represses prolif- eration of non -small cell lung cancer possibly through interaction with Neuron -Specific Enolase (NSE)[J]. Cancer Letters, 2010,289 ( 1 ) : 91-98.
  • 8Nisman B,Biran H,Ramu N,et al. The diagnostic and prognostic value of ProGRP in lung caneer[J]. Anti- cancer Res, 2009,29 (11 ) : 4827-4832.
  • 9Kochenderfer JN,Rosenberg SA.Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nat Rev Clin Oncol . 2013
  • 10Gupta Puja,Han Shuang-Yin,Holgado-Madruga Marina,Mitra Siddhartha S,Li Gordon,Nitta Ryan T,Wong Albert J.Development of an EGFRvIII specific recombinant antibody. BMC Biotechnology . 2010

共引文献57

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部